Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 1 Sponsors

Jan 13, 2026 · Senate

Introduced in the Senate, Referred to Senate Commerce Committee

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 4%, measured from NJ's completed sessions
Momentum -5 28/100 from the pace of recorded action
Time since last action -22 276 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.